XML 42 R33.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders' Equity (Deficit) (Tables)
3 Months Ended
Mar. 31, 2025
Stockholders' Equity Note [Abstract]  
Schedule of Warrants Purchase Exercise Price Range

The Company has announced that it intends to cancel all outstanding warrants, and certain language to complete this has been added to all documents related to the conversion of outstanding debts, notes, accounts payable and other senior securities. The following table summarizes the warrants outstanding on March 31, 2025, and the related prices for the warrants to purchase shares of the Company’s common stock:

  

            Weighted       Weighted 
        Weighted   average       average 
        average   exercise       exercise 
Range of   Number of   remaining   price of   Number of   price of 
exercise   warrants   contractual   outstanding   warrants   exercisable 
prices   outstanding   life (years)   warrants   exercisable   warrants 
$25.00    7,717    2.04    25.00    7,717    25.00 
 37.50    33,050    1.74    37.50    33,050    37.50 
      40,767    1.80   $35.13    40,767   $35.13 
Schedule of Stockholders' Equity Note, Warrants or Rights

The following table summarizes the transactions involving options to purchase shares of the Company’s common stock:

 

   Shares   Weighted-
Average
Exercise Price
($)
 
Outstanding at December 31, 2024   40,767   $35.13 
Granted   -   $- 
Cancelled   -   $- 
Exercised   -   $- 
Outstanding at March 31, 2025   40,767   $35.13